Back to 
Picton Mahoney Asset Management
Picton Mahoney Asset ManagementHAHAE
Showing 0 of 7 quarters
Position history for Picton Mahoney Asset Management's holdings in Haemonetics Corporation
No. Picton Mahoney Asset Management exited its HAE (Haemonetics) position in Q3 2020. Its Q2 2020 13F listed 63,820 shares worth $5.7M. Picton Mahoney Asset Management already held HAE in its Q1 2019 13F, the earliest on record, and held it in 6 quarterly 13F filings.
Current Value
—
Current Shares
—
Total Value Change
$0
Total Shares Change
0
No position history available for this security.